Article
GABA transporter 1 is a promising drug target for CUL4B mutation-associated epilepsy.
Acta pharmacologica Sinica - 1 Jun 2025
Jiang Wei, Ma Yan-Yan, Wang Yu-Feng, Jin Shi-Qi, Yu Rui-Qi, Chu Shu-Xian, Gao Yang-Fan, Wang Mo-Lin, Zou Yong-Xin, Liu Qiao, Song Yu, Zheng Yan, Zhang Chen, Sun Gong-Ping, Jiang Bai-Chun, Gong Yao-Qin
Abstract excerpt
Cullin 4B (CUL4B) is the scaffold protein in the CUL4B-RING E3 ubiquitin ligase (CRL4B) complex. Loss-of-function mutations in the human CUL4B gene result in syndromic X-linked intellectual disability (XLID). In addition to intellectual disability, patients with CUL4B mutations exhibit epilepsy. To date, the mechanism underlying epilepsy associated with CUL4B mutation has not been elucidated. Here, we show that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
